These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 9654602)
1. Recent advances in molecular genetics of cardiovascular disorders. Implications for atherosclerosis and diseases of cellular lipid metabolism. Schmitz G; Aslanidis C; Lackner KJ Pathol Oncol Res; 1998; 4(2):152-60. PubMed ID: 9654602 [TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Molecular Genetics of Cardiovascular Disorders - Implications for Atherosclerosis and Diseases of Cellular Lipid Metabolism. Schmitz G; Aslanidis C; Lackner KJ Pathol Oncol Res; 1998; 4(2):153-161. PubMed ID: 11173654 [TBL] [Abstract][Full Text] [Related]
3. Molecular genetics and gene expression in atherosclerosis. Doevendans PA; Jukema W; Spiering W; Defesche JC; Kastelein JJ Int J Cardiol; 2001; 80(2-3):161-72. PubMed ID: 11578709 [TBL] [Abstract][Full Text] [Related]
4. [Genetic factors in myocardial infarction--Results from a candidate gene and a genome-wide approach between beta blockers]. Hengstenberg C; Bröckel U; Holmer S; Mayer B; Fischer M; Baessler A; Erdmann J; Lieb W; Löwel H; Riegger G; Schunkert H Herz; 2002 Nov; 27(7):649-61. PubMed ID: 12439636 [TBL] [Abstract][Full Text] [Related]
5. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. Jensen HK Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167 [TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms involved in atherosclerosis. Soufi M; Sattler AM; Maisch B; Schaefer JR Herz; 2002 Nov; 27(7):637-48. PubMed ID: 12439635 [TBL] [Abstract][Full Text] [Related]
7. Perspective: cardiovascular disease in the postgenomic era--lessons learned and challenges ahead. Epstein JA; Rader DJ; Parmacek MS Endocrinology; 2002 Jun; 143(6):2045-50. PubMed ID: 12021168 [TBL] [Abstract][Full Text] [Related]
9. [Correlation between body mass index, lipoprotein (a) level and positive family history of cardiovascular diseases in children and adolescents with obesity, hypertension and diabetes]. Głowińska B; Urban M; Koput A Pol Merkur Lekarski; 2002 Feb; 12(68):108-14. PubMed ID: 11995245 [TBL] [Abstract][Full Text] [Related]
10. Predictive genetic testing to control coronary heart disease and hyperlipidemia. Berg K Arteriosclerosis; 1989; 9(1 Suppl):I50-8. PubMed ID: 2521445 [TBL] [Abstract][Full Text] [Related]
11. Genetic determinants of atherosclerosis-related dyslipidemias and their clinical implications. Galton DJ Clin Chim Acta; 1997 Jan; 257(2):181-97. PubMed ID: 9118562 [TBL] [Abstract][Full Text] [Related]
12. Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension. Sechi LA; Kronenberg F; De Carli S; Falleti E; Zingaro L; Catena C; Utermann G; Bartoli E JAMA; 1997 Jun; 277(21):1689-95. PubMed ID: 9169895 [TBL] [Abstract][Full Text] [Related]
15. [Reliability and power of genetic studies]. Angelico F; Del Ben M Ann Ist Super Sanita; 1992; 28(3):409-13. PubMed ID: 1492741 [TBL] [Abstract][Full Text] [Related]
16. Polymorphisms and the expression of genes encoding enzymes involved in cardiovascular diseases. Fortunato G; Di Taranto MD Clin Chim Acta; 2007 May; 381(1):21-5. PubMed ID: 17368599 [TBL] [Abstract][Full Text] [Related]
17. PCR methodology applied to genetic studies of lipoprotein metabolism and atherosclerosis. Cole SA; Hixson JE Methods Mol Biol; 1998; 110():1-34. PubMed ID: 9918036 [No Abstract] [Full Text] [Related]
18. European Lipoprotein Club: report of the 21st Annual Conference, Tutzing, September 28-October 1, 1998. Benlian P; Aalto-Setälä K; Dieplinger H; Hofker M; James R; Poledne R; Talmud P; Vilaro S Atherosclerosis; 1999 Jun; 144(2):449-58. PubMed ID: 10407507 [TBL] [Abstract][Full Text] [Related]